COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,789 Articles (22,946 medRxiv, 8,843 bioRxiv)

Most recent first Previous |  Page 1206: Articles 12051-12060  | Next

A biosafety level 2 surrogate for studying SARS-CoV-2 survival in food processing environmental biofilms
Featherstone, A. B., Dass, S. C.
10.1101/2021.10.29.466519 — Posted: 2021-11-01
Multiple spillovers and onward transmission of SARS-Cov-2 in free-living and captive White-tailed deer (Odocoileus virginianus)
Kuchipudi, S. V., Surendran-Nair, M., Ruden, R. M., Yon, M., Nissly, R. H., Nelli, R. K., Li, L., Jayarao, B. M., Vandegrift, K., Maranas, C. D., Levine, N., Willgert, K., Conlan, A. J. K., Olsen, R. J., Davis, J., Musser, J. M., Hudson, P. J., Kapur, V.
10.1101/2021.10.31.466677 — Posted: 2021-11-01
Visceral Fat Inflammation and Fat Embolism are associated with Lung's Lipidic Hyaline Membranes in COVID-19 patients
Colleluori, G., Graciotti, L., Pesaresi, M., Di Vincenzo, A., Perugini, J., Di Mercurio, E., Caucci, S., Bagnarelli, P., Zingaretti, C. M., Nisoli, E., Menzo, S., Tagliabracci, A., Ladoux, A., Dani, C., Giordano, A., Cinti, S.
10.1101/2021.10.30.466586 — Posted: 2021-11-01
Comparative genomics and characterization of SARS-CoV-2 P.1 (Gamma) Variant of Concern (VOC) from Amazonas, Brazil
Zimerman, R. A., Grohs Ferrareze, P. A., Cadegiani, F. A., Wambier, C. G., Fonseca, D. d. N., de Souza, A. R., Goren, A., Rotta, L. N., Ren, Z., Thompson, C. E.
10.1101/2021.10.30.21265694 — Posted: 2021-11-01
Anti-SARS-CoV-2 vaccination does not induce the formation of autoantibodies but provides humoral immunity following heterologous and homologous vaccination regimens: Results from a clinical and prospective study within professionals of a German University Hospital
Thurm, C., Reinhold, A., Borucki, K., Kahlfuss, S., Feist, E., Schreiber, J., Reinhold, D., Schraven, B.
10.1101/2021.11.01.21265737 — Posted: 2021-11-01
Allosteric modulation of the SARS-CoV-2 spike conformation
Diaz-Salinas, M. A., Li, Q., Ejemel, M., Wang, Y., Munro, J. B.
10.1101/2021.10.29.466470 — Posted: 2021-11-01
Efficacy and Safety of SOBERANA 02, a COVID-19 conjugate vaccine in heterologous three doses combination
Toledo-Romani, M. E., Garcia-Carmenate, M., Valenzuela Silva, C., Baldoquin-Rodriguez, W., Martinez Perez, M., Rodriguez Gonzalez, M. C., Paredes Moreno, B., Mendoza Hernandez, I., Gonzalez-Mujica Romero, R., Samon Tabio, O., Velazco Villares, P., Bacallao Castillo, J. P., Licea Martin, E., Rodriguez Ortega,, M., Herrera Marrero, N. L., Caballero Gonzalez, E., Egues Torres, L. I., Duarte Gonzalez, R., Garcia Blanco, S., Perez Cabrera, S., Huete Ferreira, S., Idalmis Cisnero, K. I., Fonte Galindo, O., Melia Perez, D., Rojas Remedios, I., Fernandez Castillo, S., Climent Ruiz, Y., Valdes Balbin, Y., Garcia Rivera, D., Verez-Bencomo, v.
10.1101/2021.10.31.21265703 — Posted: 2021-11-01
Structure-function analysis of the nsp14 N7-guanine methyltransferase reveals an essential role in Betacoronavirus replication
Ogando, N. S., El Kazzi, P., Zevenhoven-Dobbe, J. C., Bontes, B. w., Decombe, A., Posthuma, C. C. S., Thiel, V., Canard, B., Ferron, F., Decroly, E., Snijder, E. J.
10.1101/2021.05.17.444407 — Posted: 2021-11-01
Predictors of COVID testing among Australian youth: Insights from the Longitudinal Study of Australian Children
Islam, M. I., Chadwick, V., Martiniuk, A.
10.1101/2021.10.31.21265627 — Posted: 2021-11-01
Quantifying the effects of non-pharmaceutical and pharmaceutical interventions against COVID-19 epidemic in the Republic of Korea: Mathematical model-based approach considering age groups and the Delta variant
Ko, Y., Mendoza, V. M. P., Seo, Y., Lee, J., Kim, Y., Kwon, D., Jung, E.
10.1101/2021.11.01.21265729 — Posted: 2021-11-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).